Haisco Pharmaceutical's controlling shareholder adjusts share pledges

Haisco Pharmaceutical Group announced that its controlling shareholder, Wang Junmin, has extended the pledge of 23,400,000 shares, representing 0.59% of his total holdings and 0.21% of the company's total share capital. The original pledge, set to mature on November 11, 2025, has been extended to November 11, 2026, or until the completion of the pledge release registration by CITIC Securities. These shares are for the shareholder's own production and operations.

Concurrently, Wang Junmin also released the pledge of 30,300,000 shares, which constituted 0.76% of his holdings and 0.27% of the company's total share capital. This pledge, which began on November 11, 2024, matured and was released on November 11, 2025.

Following these transactions, Wang Junmin’s total pledged shares amount to 70,940,000 shares, representing 17.75% of his total holdings and 6.33% of the company's total share capital. The cumulative total pledged shares for Wang Junmin and his concerted party, Shen Ping, now stand at 70,940,000 shares, representing 16.13% of their combined holdings and 6.33% of Haisco Pharmaceutical's total share capital. Neither party has any pledged restricted or frozen shares.